A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects with Advanced Solid Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study aims to evaluate the safety, tolerability, PK profile, immunogenicity, and antitumor activity of SKB500 in subjects with advanced solid tumors.
Epistemonikos ID: 5b0547dbcf475cbb03ed5ba595e70c4bc11022f1
First added on: Jan 01, 2025